Key Takeaways CARL has begun U.S. commercialization of its aprevo cervical platform with more than 50 cases completed.CARL's AI-driven planning and 3D-printed implants showed improved alignment and workflow integration.NTAP reimbursement, FDA clearance and clinical milestones strengthened CARL's platform outlook.Carlsmed (CARL) recently announced the U.S. commercial launch of its aprevo Technology Platform for cervical fusion procedures at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting in Wa ...